Stock market week-in-review for 5 large GI companies — Aug. 7-11

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 7 to Aug. 11, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $242.55 on Aug. 7
Peaked: $245.23 on Aug. 8
Closed: $232.88 on Aug. 11
Percent change between Aug 7 to Aug. 11: -3.98 percent

2. Exact Sciences Corp.

Opened: $38.69 on Aug. 7
Peaked: $39.75 on Aug. 7
Closed: $37.76 on Aug. 11
Percent change between Aug 7 to Aug. 11: -2.40 percent

3. Johnson & Johnson

Opened: $133.11 on Aug. 7
Peaked: $134.41 on Aug. 11
Closed: $133.27 on Aug. 11
Percent change between Aug 7 to Aug. 11: 0.12 percent

4. Synergy Pharmaceuticals

Opened: $3.73 on Aug. 7
Peaked: $3.86 on Aug. 8
Closed: $2.96 on Aug. 11
Percent change between Aug 7 to Aug. 11: -20.64 percent

5. Valeant Pharmaceuticals

Opened: $15.09 on Aug. 7
Peaked: $16.89 on Aug. 8
Closed: $13.87 on Aug. 11
Percent change between Aug 7 to Aug. 11: -8.08 percent

More articles on gastroenterology: 
GI center to know: GastroIntestinal Health
Stock market week-in-review for 4 large ASC chains — Aug. 7-11
GI leader to know: Dr. Neil Price of GastroIntestinal Health

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Gastroenterology practices are hiring more advanced practice providers to cover the growing physician shortage, but many can’t keep them, according…

  • Patients who had an appendectomy for acute appendicitis had a 58% lower relative risk of a later colorectal cancer diagnosis…

Advertisement

Comments are closed.